Alpha Thalassemia Treatment Market 2019-2027 | Size, Share, Opportunities and Forecast | Credence Research

The global market for alpha thalassemia treatment was estimated at USD 526.1 million in 2018 and is expected to reach USD 965.4 million by 2027, expanding to CAGR 7.1% from 2019 to 2027.

SANJOSE, United States - June 19, 2019 /MarketersMedia/ —

According to the latest report published by Credence Research, Inc. “Alpha Thalassemia Treatment Market - Growth, Future Prospects and Competitive Analysis, 2019-2027,” the global alpha thalassemia treatment market was valued at USD 526.1 Mn in 2018, and is expected to reach USD 965.4 Mn by 2027, expanding at a CAGR of 7.1% from 2019 to 2027.

Market Insights

Alpha thalassemia causes due to deficiency or absence of alpha globin chains results in alpha thalassemia which is asymptomatic with general hematologic findings and gains silent carrier status. The alpha thalassemia is categorized as alpha thalassemia, hemoglobin H-constant spring, silent carrier, hemoglobin H disease, alpha thalassemia trait, and alpha thalassemia major. Alpha thalassemia is caused specifically due to two different genes such as HBA1 and HBA2 genes. Alpha thalassemia is found worldwide in several regions but most commonly in the Southeast Asia, Middle East, and certain Mediterranean countries. According to The California Newborn Screening Program, the high birth prevalence rate of alpha thalassemia major (ATM) was identified in immigrant women from Vietnam, China, and Philippines which reflects the migration patterns and its effects in this region.

Browse the full report Alpha Thalassemia Treatment Market - Growth, Future Prospects and Competitive Analysis, 2019-2027 report at https://www.credenceresearch.com/report/alpha-thalassemia-treatment-market

In 2018, Deferasirox was identified as the largest drug segment in alpha thalassemia treatment market due to key factors such as it is currently the only USFDA approved drug for alpha thalassemia treatment, and increasing awareness related to thalassemia in medical practitioners & patients from developing countries. However, folic acid plays crucial role in alpha thalassemia management which makes it one of the crucial element of treatment regimen.

In 2018, North America was identified as the largest alpha thalassemia treatment market due to increasing entry of immigrants in the United States and Canada specifically from Asia and rising awareness related to alpha thalassemia in patients as well as medical practitioners is expected to assist the growth in the near future. However, Middle East & Africa is identified as the fastest growing alpha thalassemia market due to high prevalence of alpha thalassemia, and rising awareness related to rare hematological diseases.

Market Competition Assessment:

The alpha thalassemia treatment market is growing gradually and key companies operating in this market are developing treatments that are safe and target-specific. The major companies available in the global market are bluebird bio, Inc., Acceleron Pharma, Inc., Novartis AG, Celgene Corporation, Shire Plc. (Takeda Pharmaceuticals), Incyte Corporation, Kiadis Pharma, and GlaxoSmithKline among others.

Key Market Movements:

Rising awareness and prevalence related to alpha thalassemia treatment & diagnosis expected to assist the market growth
Incessant growth in research & development of alpha thalassemia treatment will assist the growth in demand for safe & efficient treatment options
Mounting diagnosis rate related to developing countries will increase the demand for alpha thalassemia treatment market
Strong drug pipeline anticipated to increase the CAGR of the overall market in the near future

Request For The Sample: https://www.credenceresearch.com/sample-request/59721

ToC:
Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
............

Chapter 3. Global Alpha Thalassemia Treatment Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2018
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2018

Chapter 4. Global Alpha Thalassemia Treatment Market, by Type of Drugs, 2017 – 2027 (US$ Mn)
4.1. Overview
4.2. Folic Acid
4.3. Deferasirox
4.4. Deferiprone
4.5. Hydroxyurea

Chapter 5. Global Alpha Thalassemia Treatment Market, Pipeline Analysis
...........

Chapter 6. Global Alpha Thalassemia Treatment Market, by Geography, 2017 – 2027 (US$ Mn)
............

Chapter 7. Company Profiles
7.1. GlaxoSmithKline Plc
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Bellicum Pharmaceuticals
7.3. Novartis AG
7.4. Acceleron Pharma
7.5. Johnson & Johnson
7.6. Merck & Co Inc.
7.7. Alnylam Pharmaceuticals Inc.
7.8. Calimmune Inc.
7.9. Editas Medicine Inc.
7.10. Gilead Sciences Inc.
.................toc continued

Browse the full report Alpha Thalassemia Treatment Market - Growth, Future Prospects and Competitive Analysis, 2019-2027 report at https://www.credenceresearch.com/report/alpha-thalassemia-treatment-market

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com

Source URL: https://marketersmedia.com/alpha-thalassemia-treatment-market-2019-2027-size-share-opportunities-and-forecast-credence-research/526750

Source: MarketersMedia

Release ID: 526750

Latest News

Companies reach tentative deal to settle opioids lawsuit

Oct 23, 2019

CLEVELAND — The nation's three dominant drug distributors and a big drugmaker have reached a tentative deal to settle a lawsuit related to the opioid crisis just as the first federal trial over the crisis was due to begin Monday, according to a lead lawyer for the local governments suing the drug industry. The tentative deal, details of which were to be announced later Monday, settles claims brought by the Ohio counties of Cuyahoga and Summit against distributors AmerisourceBergen, Cardinal Health and McKessen and the manufacturer Teva. After five drug manufacturers, including Johnson & Johnson, reached settlements leading up to...

Schumer calls for federal probe of contaminated baby food

Oct 23, 2019

NEW YORK — The Senate's top Democrat is calling on the Food and Drug Administration to examine a report that found dozens of baby food products contaminated with lead and other metals. Sen. Chuck Schumer says Sunday the FDA must take more action to regulate the baby food industry. A study by Healthy Babies Bright Futures found the presence of heavy metals in 95% of the 168 baby foods that were tested. The study found 95% of the food tested contained lead, arsenic, mercury or cadmium. It found one in four baby foods that were tested contained all four metals....

The Latest: Officials: Be kind to PG&E workers amid shut-off

Oct 23, 2019

SAN FRANCISCO — The Latest on power outages in California (all times local): 4:15 p.m. Authorities are asking the public to be kind to frontline utility workers in California as anger mounts against Pacific Gas and Electric over a power shutdown. PG&E is cutting power to customers in 34 counties as dry, gusty winds create dangerous wildfires conditions. The utility's faulty equipment was to blame for a deadly fire a year ago that killed 85 people and nearly wiped out the town of Paradise. Sacramento's KCRA-TV says the California Highway Patrol is investigating an incident Tuesday in Colusa County in...

Legos lying around? Toy maker tests way to recycle bricks

Oct 23, 2019

NEW YORK — Lego is looking to keep its plastic bricks out of the trash. The Danish toymaker is testing a way for customers to ship their unwanted bricks back and get them into the hands of other kids. It said Tuesday that customers in the U.S. can print out a mailing label on its site, dump their used Lego bricks in a box and ship them off for free. Lego said the pieces will be cleaned, put in a box and given to Teach for America, a nonprofit that will donate them to classrooms across the United States. Some...

Police: 3 dead, 1 missing after car plunges into canal

Oct 23, 2019

MIDDLETOWN, Del. — A car with five occupants plunged into a Delaware canal on Sunday and the driver helped a teenage girl to safety before dying in a bid to rescue three other passengers, two of whom were found dead after the car was hoisted from the water, authorities said. Delaware State Police said they initially found the body of the 18-year-old male driver in the water after he had helped a 16-year-old girl make it safely to shore. A police statement said two more passengers, boys ages 12 and 16, were pronounced dead hours later after the car they...

Emporium Post fulfils the need to know all things about consumers and how businesses can take this opportunity to reach their own customers.

Contact us: sales@emporiumpost.com

Join our mailing list now!